Uterine Rupture

Uterine Sarcomas

Uterine Fibroids

Dysfunctional Uterine Bleeding DUB

Uterine and Vaginal Prolapse

Nonsurgical Treatment For Uterine Fibroids: Hormone Acting Drugs With Uterine Artery Embolization

Women with uterine fibroids larger than 10 cm have a new nonsurgical treatment choice - hormone acting drugs followed by uterine artery embolization, a new study shows. The new treatment option can re...

Prediction of Preeclampsia by Combining Serum Histidine-Rich Glycoprotein and Uterine Artery Doppler

Hormone acting drugs + uterine artery embolization offers nonsurgical treatment for uterine fibroids

Women with uterine fibroids larger than 10 cm have a new nonsurgical treatment choice –hormone acting drugs followed by uterine artery embolization, a new study shows. The new treatment option ca...

First-trimester serum soluble fms-like tyrosine kinase-1, free vascular endothelial growth factor, placental growth factor and uterine artery Doppler in preeclampsia

Bilateral uterine artery chemoembolization terminates cesarean scar pregnancy

NEW YORK (Reuters Health) - Bilateral uterine artery chemoembolization with methotrexate safely and effectively terminates cesarean scar pregnancy (CSP), a new study has found.

Fibroid embolization fails more in young women

NEW YORK (Reuters Health) - Young women who undergo uterine artery embolization for uterine fibroids are more likely to have a recurrence than older women are, a new study finds.

Scientists Uncover Genetic Link for Uterine Fibroids

THURSDAY, Oct. 4 -- Researchers who discovered genetic risk factors linked to uterine fibroids in white women say their findings will lead to new screening and treatment methods for the condition. Ute...

Childhood Abuse May Be Tied to Uterine Fibroids: Study

WEDNESDAY, Jan. 30 (HealthDay News) -- Black women who suffered sexual or physical abuse as children may be at increased risk for uterine fibroids, a new study has found. Uterine fibroids -- which ca...

Maternal serum visfatin at 11-13 weeks' gestation in preeclampsia.

The objective of this study was to determine if the maternal serum levels of visfatin in the first trimester of pregnancy are altered in cases that develop preeclampsia (PE) and whether the levels are...

Maternal serum insulin-like growth factor-I at 11-13 weeks in preeclampsia.

OBJECTIVE: To investigate the maternal serum concentration of insulin-like growth factor-I (IGF-I) in the first trimester of pregnancies that subsequently develop preeclampsia (PE) and to examine the...

Role of ovarian artery-to-uterine artery anastomoses in uterine artery embolization: initial anatomic and radiologic studies.

PURPOSE: To explore the anatomic features of normal human ovarian artery-to-uterine artery anastomoses and their impact on uterine artery embolization (UAE)....

Aberrant Ovarian Collateral Originating from External Iliac Artery During Uterine Artery Embolization.

We report a case of a 35-year-old woman who underwent uterine artery embolization (UAE) for symptomatic multiple uterine fibroids with collateral aberrant right ovarian artery that originated from the...

Maternal Serum Human Placental Growth Hormone (hPGH) at 11 to 13 Weeks of Gestation in Preeclampsia.

Objective. Human placental growth hormone (hPGH) is produced by human placenta and plays a central role in the maternal metabolic adjustments to pregnancy. The objective of this study was to investiga...